Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Baxter
Cantor Fitzgerald
US Department of Justice
Mallinckrodt
Deloitte
Julphar
Dow

Generated: December 10, 2018

DrugPatentWatch Database Preview

DEXTROAMPHETAMINE SULFATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dextroamphetamine sulfate and what is the scope of dextroamphetamine sulfate patent protection?

Dextroamphetamine sulfate is the generic ingredient in five branded drugs marketed by Impax Labs Inc, Able, Actavis Elizabeth, Mayne Pharma, Mylan Pharms Inc, Nesher Pharms, Specgx Llc, Vintage Pharms, Teva, Glaxosmithkline, Outlook Pharms, Tris Pharma Inc, Ani Pharms Inc, Arbor Pharms Llc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vintage Pharms Llc, Vitarine, Shire, and Ferndale Labs, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for dextroamphetamine sulfate. Twenty-four suppliers are listed for this compound.

Pharmacology for DEXTROAMPHETAMINE SULFATE
Medical Subject Heading (MeSH) Categories for DEXTROAMPHETAMINE SULFATE

US Patents and Regulatory Information for DEXTROAMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 206735-003 Jan 27, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040365-001 Oct 31, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 076353-003 May 6, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Elizabeth DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 203901-002 Nov 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040299-001 May 13, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Avanthi Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 203548-002 Nov 23, 2015 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
Merck
Dow
Daiichi Sankyo
QuintilesIMS
Moodys
Cantor Fitzgerald
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.